Helix BioMedix, Inc.
HXBM
$7.18
-$0.01-0.14%
OTC PK
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Revenue | 2.07M | 1.99M | 2.21M | 1.89M | 1.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.07M | 1.99M | 2.21M | 1.89M | 1.80M |
| Cost of Revenue | 641.20K | 633.80K | 822.00K | 733.30K | 683.50K |
| Gross Profit | 1.42M | 1.36M | 1.39M | 1.16M | 1.12M |
| SG&A Expenses | 3.37M | 3.16M | 3.09M | 2.90M | 2.80M |
| Depreciation & Amortization | 94.70K | 99.60K | 105.60K | 109.10K | 109.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.49M | 4.26M | 4.39M | 4.24M | 4.19M |
| Operating Income | -2.42M | -2.27M | -2.17M | -2.35M | -2.39M |
| Income Before Tax | -2.58M | -2.40M | -2.36M | -2.49M | -6.66M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.58 | -2.40 | -2.36 | -2.49 | -6.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.58M | -2.40M | -2.36M | -2.49M | -6.66M |
| EBIT | -2.42M | -2.27M | -2.17M | -2.35M | -2.39M |
| EBITDA | -2.33M | -2.17M | -2.07M | -2.24M | -2.28M |
| EPS Basic | -15.59 | -14.51 | -14.24 | -15.02 | -56.63 |
| Normalized Basic EPS | -9.72 | -9.08 | -8.64 | -9.18 | -12.54 |
| EPS Diluted | -15.59 | -14.51 | -14.24 | -15.02 | -56.63 |
| Normalized Diluted EPS | -9.72 | -9.08 | -8.64 | -9.18 | -12.54 |
| Average Basic Shares Outstanding | 662.80K | 662.80K | 662.80K | 662.80K | 602.20K |
| Average Diluted Shares Outstanding | 662.80K | 662.80K | 662.80K | 662.80K | 602.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |